Fol. Biol. 2013, 59, 87-92

https://doi.org/10.14712/fb2013059020087

Promoter Methylation of GATA4, WIF1, NTRK1 and Other Selected Tumour Suppressor Genes in Ovarian Cancer

Marcela Chmelařová1, E. Dvořáková2, J. Špaček2, J. Laco3, M. Mžik1, V. Palička1

1Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic
2Department of Obstetrics and Gyneacology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic
3The Fingerland Department of Pathology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic

Received October 2012
Accepted January 2013

References

1. Abou-Zeid, A. A., Azzam, A. Z., Kamel, N. A. (2011) Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer. Scand. J. Clin. Lab. Invest. 71, 542-547. <https://doi.org/10.3109/00365513.2011.590224>
2. Asadollahi, R., Hyde, C. A., Zhong, X. Y. (2010) Epigenetics of ovarian cancer: from the lab to the clinic. Gynecol. Oncol. 118, 81-87. <https://doi.org/10.1016/j.ygyno.2010.03.015>
3. Bol, G. M., Suijkerbuijk, K. P., Bart, J., Vooijs, M., van der Wall, E., van Diest, P. J. (2010) Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology 57, 363-370. <https://doi.org/10.1111/j.1365-2559.2010.03642.x>
4. Chan, K. Y., Ozçelik, H., Cheung, A. N., Ngan, H. Y., Khoo, U. S. (2002) Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res. 62, 4151-4156.
5. Chmelarova, M., Krepinska, E., Spacek, J., Laco, J., Beranek, M., Palicka, V. (2013) Methylation in the p53 promoter in epithelial ovarian cancer. Clin. Transl. Oncol. 15, 160-163. <https://doi.org/10.1007/s12094-012-0894-z>
6. Deng, Y., Yu, B., Cheng, Q., Jin, J., You, H., Ke, R., Tang, N., Shen, Q., Shu, H., Yao, G., Zhang, Z., Qin, W. (2010) Epigenetic silencing of WIF-1 in hepatocellular carcinomas. J. Cancer Res. Clin. Oncol. 136, 1161-1167. <https://doi.org/10.1007/s00432-010-0763-5>
7. Dong, R., Yu, J., Pu, H., Zhang, Z., Xu, X. (2012) Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer. J. Int. Med. Res. 40, 681-686. <https://doi.org/10.1177/147323001204000231>
8. Feng, W., Marquez, R. T., Lu, Z., Liu, J., Lu, K. H., Issa, J. P., Fishman, D. M., Yu, Y., Bast, R. C. Jr. (2008) Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112, 1489-1502. <https://doi.org/10.1002/cncr.23323>
9. Gras, E., Catasus, L., Argüelles, R., Moreno-Bueno, G., Palacios, J., Gamallo, C., Matias-Guiu, X., Prat, J. (2001) Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 92, 2829-2836. <https://doi.org/10.1002/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3>
10. Guo, M., Akiyama, Y., House, M. G., Hooker, C. M., Heath, E., Gabrielson, E., Yang, S. C., Han, Y., Baylin, S. B., Herman, J. G., Brock, M. V. (2004) Hypermethylation of the GATA genes in lung cancer. Clin. Cancer Res. 10, 7917-7924. <https://doi.org/10.1158/1078-0432.CCR-04-1140>
11. Guo, M., House, M. G., Akiyama, Y., Qi, Y., Capagna, D., Harmon, J., Baylin, S. B., Brock, M. V., Herman, J. G. (2006) Hypermethylation of the GATA gene family in esophageal cancer. Int. J. Cancer 119, 2078-2083. <https://doi.org/10.1002/ijc.22092>
12. Hellebrekers, D. M., Lentjes, M. H., van den Bosch, S. M., Melotte, V., Wouters, K. A., Daenen, K. L., Smits, K. M., Akiyama, Y., Yuasa, Y., Sanduleanu, S., Khalid-de Bakker, C. A., Jonkers, D., Weijenberg, M. P., Louwagie, J., van Criekinge, W., Carvalho, B., Meijer, G. A., Baylin, S. B., Herman, J. G., de Bruïne, A. P., van Engeland, M. (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin. Cancer Res. 15, 3990-3997. <https://doi.org/10.1158/1078-0432.CCR-09-0055>
13. Ibanez de Caceres, I., Battagli, C., Esteller, M., Herman, J. G., Dulaimi, E., Edelson, M. I., Bergman, C., Ehya, H., Eisenberg, B. L., Cairns, P. (2004) Tumour cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res. 64, 6476-6481. <https://doi.org/10.1158/0008-5472.CAN-04-1529>
14. Jones, P. A., Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-692. <https://doi.org/10.1016/j.cell.2007.01.029>
15. Karlan, B. Y. (2009) Patients at high risk for ovarian cancer should undergo routine screening. Clin. Ovarian Cancer 5, 83-89. <https://doi.org/10.3816/COC.2009.n.015>
16. Mei, F. C., Young, T. W., Liu, J., Cheng, X. (2006) RASmediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J. 20, 497-499. <https://doi.org/10.1096/fj.05-4586fje>
17. Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., Jablons, D. M. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 64, 4717-4720. <https://doi.org/10.1158/0008-5472.CAN-04-1389>
18. Moelans, C. B., Verschuur-Maes, A. H., van Diest, P. J. (2011) Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J. Pathol. 225, 222-231. <https://doi.org/10.1002/path.2930>
19. Montavon, C., Gloss, B. S., Warton, K., Barton, C. A., Statham, A. L., Scurry, J. P., Tabor, B., Nguyen, T. V., Qu, W., Samimi, G., Hacker, N. F., Sutherland, R. L., Clark, S. J., O’Brien, P. M. (2012) Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecol. Oncol. 124, 582-588. <https://doi.org/10.1016/j.ygyno.2011.11.026>
20. Nygren, A. O., Ameziane, N., Duarte, H. M., Vijzelaar, R. N., Waisfisz, Q., Hess, C. J., Schouten, J. P., Errami, A. (2005) Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33, e128. <https://doi.org/10.1093/nar/gni127>
21. Pavicic, W., Perkiö, E., Kaur, S., Peltomäki, P. (2011) Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MSMLPA)-based approach. Mol. Med. 17, 726-735. <https://doi.org/10.2119/molmed.2010.00239>
22. Taniguchi, H., Yamamoto, H., Hirata, T., Miyamoto, N., Oki, M., Nosho, K., Adachi, Y., Endo, T., Imai, K., Shinomura, Y. (2005) Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24, 7946-7952. <https://doi.org/10.1038/sj.onc.1208910>
23. Tapia, V., Gabler, F., Muñoz, M., Yazigi, R., Paredes, A., Selman, A., Vega, M., Romero, C. (2011) Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer. Gynecol. Oncol. 121, 13-23. <https://doi.org/10.1016/j.ygyno.2010.12.341>
24. Tavassoli, F. A, Devilee, P. (Eds.) (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, 113-202.
25. Wakana, K., Akiyama, Y., Aso, T., Yuasa, Y. (2006) Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis. Cancer Lett. 241, 281-288. <https://doi.org/10.1016/j.canlet.2005.10.039>
26. Wen, X. Z., Akiyama, Y., Pan, K. F., Liu, Z. J., Lu, Z. M., Zhou, J., Gu, L. K., Dong, C. X., Zhu, B. D., Ji, J. F., You, W. C., Deng, D. J. (2010) Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J. Gastroenterol. 16, 1201-1208. <https://doi.org/10.3748/wjg.v16.i10.1201>
27. Yoon, J. H., Dammann, R., Pfeifer, G. P. (2001) Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Int. J. Cancer 94, 212-217. <https://doi.org/10.1002/ijc.1466>
28. Zhuang, J., Jones, A., Lee, S. H., Ng, E., Fiegl, H., Zikan, M., Cibula, D., Sargent, A., Salvesen, H. B., Jacobs, I. J., Kitchener, H. C., Teschendorff, A. E., Widschwendter, M. (2012) The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women’s cancer. PLoS Genet. 8, e1002517. <https://doi.org/10.1371/journal.pgen.1002517>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive